Dolby Laboratories (DLB)
Return on equity (ROE)
Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net income (ttm) | US$ in thousands | 261,825 | 212,441 | 190,396 | 188,262 | 200,656 | 219,226 | 242,424 | 183,448 | 184,087 | 200,522 | 215,546 | 255,043 | 310,227 | 292,865 | 305,529 | 317,808 | 231,363 | 248,452 | 220,741 | 205,685 |
Total stockholders’ equity | US$ in thousands | 2,477,160 | 2,432,850 | 2,420,900 | 2,345,850 | 2,355,100 | 2,366,240 | 2,350,780 | 2,287,580 | 2,246,180 | 2,454,360 | 2,599,770 | 2,637,750 | 2,597,980 | 2,621,520 | 2,587,930 | 2,565,160 | 2,432,640 | 2,431,370 | 2,364,060 | 2,333,290 |
ROE | 10.57% | 8.73% | 7.86% | 8.03% | 8.52% | 9.26% | 10.31% | 8.02% | 8.20% | 8.17% | 8.29% | 9.67% | 11.94% | 11.17% | 11.81% | 12.39% | 9.51% | 10.22% | 9.34% | 8.82% |
September 30, 2024 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $261,825K ÷ $2,477,160K
= 10.57%
Dolby Laboratories' return on equity (ROE) has shown some fluctuations over the past five years. The ROE ranged from a low of 7.86% in March 2024 to a high of 12.39% in December 2020. It is important to note that the ROE has generally been above 8% during this period, indicating that the company has been generating a decent return for its shareholders relative to the equity they have invested.
The trend in ROE appears to have some variability, with periods of increase followed by slight declines. For example, there was a noticeable increase in ROE from September 2022 to March 2023, followed by a decline in the subsequent quarters. However, the ROE has generally remained above 8% in recent quarters, suggesting consistent, albeit moderate, profitability relative to shareholders' equity.
Overall, Dolby Laboratories' ROE performance indicates that the company has been effectively utilizing its shareholders' equity to generate profits. It is essential for investors to monitor future trends in ROE to assess the company's ability to maintain and potentially improve its profitability in the long term.
Peer comparison
Sep 30, 2024